ArticleTranslational andrology and urology2025

Efficacy at a cost?-quality of life implications of PARP inhibition in the homologus recombination repair (HRR) cohort of TALAPRO-2.

Jorge Esteban-Villarrubia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.